| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 2003 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.200 | None | 0.892 | 36 | 4 | 1994 | 2019 | ||||||||
|
thioredoxin domain containing 12 | 0.839 | 0.154 | 3.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 1.000 | 15 | 1 | 1996 | 2019 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2004 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2005 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2000 | 2018 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2001 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2011 | |||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2002 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 2 | 2002 | 2017 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2002 | 2008 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2007 | ||||||||
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2004 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2013 | ||||||||
|
complement C3b/C4b receptor 1 (Knops blood group) | 0.533 | 0.808 | 1.6E-35 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2009 |